Breaking News

 
30 November 2009
Urea-based moisturizer delayed atopic dermatitis relapse in a prospective, randomized, controlled trial
 
27 November 2009
Patients with moderate-severe psoriasis regain clinical response during etanercept retreatment
 
26 November 2009
Adapalene-benzoyl peroxide topical gel for acne vulgaris: A controlled study versus its components and vehicle
 
25 November 2009
Twice-daily versus once-daily topical pimecrolimus cream for relapse prevention in pediatric atopic dermatitis
 
24 November 2009
Adalimumab therapy for severe recalcitrant chronic plaque psoriasis
 
23 November 2009
Sensitivity and specificity of multiphoton laser tomography for melanoma diagnosis
 
20 November 2009
Two regimens of topical steroid therapy for bullous pemphigoid: A controlled study
 
19 November 2009
A cohort study of vitamin D intake and melanoma risk
 
18 November 2009
Probiotics during weaning reduce eczema incidence
 
17 November 2009
Platelet P-selectin as a biomarker of inflammation in psoriasis
 
16 November 2009
Consensus statement on the management of chronic hand eczema
 
13 November 2009
Retrospective cohort study on the impact of biologics on medical resource use, cost and outcomes in psoriasis patients
 
12 November 2009
The itch severity scale: A tool to assess pruritus in atopic dermatitis
 
11 November 2009
An empirically validated threshold value in assessing facial acne lesion count changes
 
09 November 2009
Diagnostic markers in cutaneous CD30-positive lymphoproliferations
 
05 November 2009
Association between psoriasis and inflammatory bowel disease identified
 
11 August 2009
Serum levels of transforming growth factor beta-1 in psoriasis patients: Effects of biological drugs
 
11 June 2009
Target Nail Psoriasis Severity Index: A clinically useful tool for assessing nail psoriasis severity
 
11 May 2009
Health-related utility and cost-effectiveness of topical tacrolimus or corticosteroids for adult atopic dermatitis
 
11 March 2009
High-dose IFN-alpha therapy promotes effector/memory T-cell subset in stage III malignant melanoma
 
 
12next